DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

39.05 -1.00 (-2.50%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NBIX $39.05 -2.50%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.00
Previous Close $40.05
Daily Range $38.65 - $40.50
52-Week Range $12.17 - $40.75
Market Cap $3.0B
P/E Ratio -49.44
Dividend (Yield) $0.00 (0.0%)
Volume 1,825,819
Average Daily Volume 1,155,637
Current FY EPS -$1.05

Sector

Healthcare

Industry

Drug Makers

Neurocrine Biosciences, Inc. (NBIX) Description

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/

News & Commentary

NBIX's Top Competitors

NBIX $39.05 (-2.50%)
Current stock: NBIX
AMGN $157.72 (-0.79%)
Current stock: AMGN
GILD $103.53 (-0.63%)
Current stock: GILD
BIIB $409.59 (-0.12%)
Current stock: BIIB